| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2143845 | Lung Cancer | 2006 | 6 Pages |
Abstract
SummaryIntroductionLung cancer is the leading cause of tumour-related deaths in the elderly population but the optimal management of advanced NSCLC in older patients has not been defined to date. The present phase II study was planned to evaluate the efficacy and toxicity of the combination of carboplatin and paclitaxel in elderly patients with advanced NSCLC.Patients and methodsPatients (>70 years old) who had pathologically been proven
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Carmelo Giannitto Giorgio, Alessandro Pappalardo, Antonio Russo, Dario Giuffrida, Daniele Santini, Giuseppina Petralia, Sergio Castorina, Restuccia Nunzio, Giuseppe Failla, Roberto Bordonaro,